World Health Organization Report Finds Possible Health Benefits and No Addictive Potential in CBD


With a growing abundance of relevant pre-clinical and clinical research, the World Health Organization has recently issued positive recommendations regarding cannabidiol (CBD).  In a 2017 meeting held by the WHO, the Expert Committee on Drug Dependence (ECDD) released a fairly positive pre-review of CBD, stating it found no addictive potential and suggesting possible medical benefits (1, 2).

While the WHO’s pre-reviews of cannabis and cannabis related substances have set the release of the Cannabis and Related Substances Critical Report to November 2018, the CBD Critical Review Report  released June 2018  concluded and recommended the following:

  • …that “preparations considered to be pure CBD should not be scheduled within the International Drug Control Conventions” (2)
  • …that “In humans, CBD exhibits no effects indicative of any abuse or dependence potential” (2)
  • “CBD has been demonstrated as an effective treatment of epilepsy in several clinical trials” and “there is also preliminary evidence that CBD may be a useful treatment for a number of other medical conditions” (2)
  • “CBD is generally well tolerated with a good safety profile”